Cover Image

Development of ELISA techniques for haemorrhagic septicaemia

Subhash Kharb


Haemorrhagic septicaemia (HS) caused by Pasteurella multocida serotypes B:2 and E:2 in Asian and African countries respectively is a major epizootic disease of cattle and buffaloes with heavy morbidity and mortality. Being simple, rapid, inexpensive and easy for automation, ELISA has emerged as an important tool for diagnosis as well as monitoring the immune status of animals vaccinated against HS in laboratories. In the present review, development of ELISA techniques for diagnosis, sero-surveillance of immune status in vaccinated animals and DIVA strategy for the evaluation of various HS control programmes have been discussed. Among the various variants, indirect-ELISA has been found most commonly used format for sero-surveillance against HS vaccines and quantification of antibody responses in different vaccine formulation trails. The development of monoclonal antibodies based ELISA have increased the specificity and sensitivity of the test.


ELISA; Haemorrhagic septicaemia; Pasteurella multocida B:2; Sero-surveillance

Full Text:



De Alwis, MCL. “Haemorrhagic Septicaemia – A General Review.” British Veterinary Journal 148.2 (1992): 99-112. Print

OIE. “Haemorrhagic septicaemia, Chapter 2.4.12. Terrestrial manual, Paris, France.” (2009): 739-750. Print

Annas, S, M Zamri-Saad, FF Jesse, and Z Zunita. “Comparative Clinicopathological Changes in Buffalo and Cattle following infection by Pasteurella multocida B:2.” Microbial Pathogenesis 88 (2015): 94-102. Print

Shivachandra, SB, KN Viswas, and AA Kumar. “A Review of Hemorrhagic Septicaemia in Cattle and Buffalo.” Animal Health Research Reviews 12.1 (2011): 67-82. Print

Benkirane, A, and MCL De Alwis. “Haemorrhagic Septicaemia, Its Significance, Prevention and Control in Asia.” Veterinary Medicine Czech 47.8 (2002): 234-240. Print

De Alwis, MCL, TG Wijewardana, AI Gomis, and AA Vipulasiri. “Persistence of the Carrier Status in Haemorrhagic Septicaemia (Pasteurella multocida serotype 6:B infection) in Buffaloes.” Tropical Animal Health and Production 22.3 (1990): 185-194. Print

Harper, M, JD Boyce, and B Adler. “Pasteurella multocida Pathogenesis: 125 Years after Pasteur.” FEMS Microbiology Letters 265.1 (2006): 1-10. Print

Carpenter, AB. “Enzyme Linked Immunoassays, In. Rose, NR, EC de Macario, JD Folds, HC Lane, and RM Nakamura, Manual of Clinical Immunology Ed 5th, ASM, Washington DC.” (1997): 20-30. Print

Engvall, E, and P Perlmann. “Enzyme-Linked Immunosorbent Assay (ELISA). Quantitative Assay of Immunoglobulin G.” Immunochemistry 8.9 (1971): 871-874. Print

Lequin, RM. “Enzyme Immunoassay (EIA)/ Enzyme-Linked Immunosorbent Assaay (ELISA).” Clinical Chemistry 51.12 (2005): 2415-2418. Print

Dawkins, HJS, Ramdani, RB Johnson, and TL Spencer. “Haemorrhagic Septicaemia: Correlation of Vaccinal Antibody Responses in Mice with Protection against Pasteurella multocida strain M1404.” Veterinary Microbiology 27.3 (1991): 309-326. Print

Dawkins, HJS, RB Johnson, TL Spencer, and BE Patten. “Rapid Identification of Pasteurella multocida Organisms Responsible for Haemorrhagic Septicaemia using an Enzyme-Linked Immunosorbent Assay.” Research in Veterinary Science 49.3 (1990): 261-267. Print

Petersen, A, M Bisgaard, K Townsend, and H Christensen. “MLST Typing of Pasteurella multocida associated with Haemorrhagic Septicaemia and Development of a real-time PCR specific for Haemorrhagic Septicaemia associated isolates.” Veterinary Microbiology 170.3 (2014): 335-341. Print

El-Jakee, JK, SS Ali, SA El-Shafii, AM Hessain, AA Al-Arfaj, and MI Mohamed. “Comparative Studies for Serodiagnosis of Haemorrhagic Septicaemia in Cattle Sera.” Saudi Journal of Biological Sciences (2015) (in press). Print

Johnson, RB, HJS Dawkins, TL Spencer, AA Saharee, AR Bahaman, Ramdin, and BE Patten. “Evaluation of Bovine Antibody Response to a strain of Pasteurella multocida known to cause Haemorrhagic Septicaemia.” Research in Veterinary Science 47.2 (1989): 207-209. Print

Anonymous, “Project completion report on Development of Monoclonal Antibody and Outer membrane Proteins based ELISA kit for Monitoring Immune Status of Animals Vaccinated with HS.” submitted to Department of Biotechnology, Govt. of India (2005).

Kumar, A, and NK Kakkar. “Annual Report-Monitoring Immune Status of Cattle and Buffaloes Vaccinated against Haemorrhagic Septicaemia in the state of Haryana.” (2006) Department of Veterinary Microbiology, CCSHAU, Hisar. Print

Kumari, L, S Kumar, A Kumar, NK Mahajan, BL Pander, and RS Khokhar. “Seromonitoring of Cattle and Buffaloes Vaccinated against Haemorrhagic septicaemia using Monoclonal Antibody based indirect-ELISA.” Journal of Immunology and Immunopathology 9.1 (2007): 67-70. Print

Markam, SK, RS Khokhar, NK Mahajan, A Kumar, SK Kadian, and S Kapoor. “Monoclonal Antibody based ELISA for Seromonitoring of Bovines Vaccinated against Haemorrhagic Septicaemia in Haryana.” The Haryana Veterinarian 48 (2009): 88-90. Print

Kumar, P, and A Kumar. “Development and Standardization of a Blocking ELISA based on Monoclonal Antibody to Pasteurella multocida.” The Haryana Veterinarian 52 (2013): 90-92. Print

Qureshi, S, and HM Saxena. “Estimation of Titers of Antibody against Pasteurella multocida in Cattle Vaccinated with Haemorrhagic Septicemia Alum Precipitated Vaccine.” Veterianry World 7.4 (2014): 224-228. Print

Afzal, M, R Muneer, and S Akhtar. “Serological Evaluation of Pasteurella multocida Antigens associated with Protection in Buffalo Calves.” Revue Scientifique et Technique (International Office of Epizootics) 11.3 (1992): 917-923. Print

Pati, US, SK Srivastava, SC Roy, and T More. “Immunogenicity of Outer Membrane Protein of Pasteurella multocida in Buffalo Calves.” Veterinary Microbiology 52.3 (1996): 301-311. Print

Basagoudanavar, SH, DK Singh, and BC Varshney. “Immunization with Outer Membrane Proteins of Pasteurella multocida (6:B) provides Protection in Mice.” Journal of Veterinary Medicine A: Physiological, Pathological and Clinical Medicine 53.10 (2006): 524-530. Print

Kharb, S, and S Charan. “Immunogenicity of Iron-Regulated Outer Membrane Proteins of Pasteurella multocida B:2 in Mice Model.” Indian Journal of Experimental Biology 48.12 (2010): 1181-1187. Print

Kharb, S, and S Charan. “Estimation of Antibodies against Pasteurella multocida B:2 in Serum employing ELISA: Comparision of Different Blocking Reagents.” International Journal of Bioassays 2.5 (2013): 748-750. Print

Tan, HY, NH Nagoor, and SD Sekaran. “Cloning, Expression and Protective Capacity of 37 kDa Outer Membrane Protein Gene (ompH) of Pasteurella multocida serotype B:2.” Tropical Biomedicine 27.3 (2010): 430-441. Print

Joshi, S, K Tewari, and R Singh. “Comparative Immunogenicity and Protective Efficacy of Different Preparations of Outer Membrane Proteins of Pasteurella multocida (B:2) in a Mouse Model.” Veterinarski Archiv 83.6 (2013): 665-676. Print

Kumar, A, R Yogisharadhya, MA Ramakrishnan, KN Viswas, and SB Shivachandra. “Structural Analysis and Cross-protective Efficacy of Recombinant 87 kDa Outer Membrane Protein (Omp87) of Pasteurella multocida serogroup B:2.” Microbial Pathogenesis 65 (2013): 48-56. Print

Shivachandra, SB, A Kumar, R Yogisharadhya, and KN Viswas. “Immunogenicity of Highly Conserved Recombinant VacJ Outer Membrane Lipoprotein of Pasteurella multocida.” Vaccine 32.2 (2014): 290-296. Print

Shivachandra, SB, R Yogisharadhya, A Kumar, NN Mohanty, and VK Nagaleekar. “Recombinant Transferrin Binding Protein A (rTbpA) fragments of Pasteurella multocida serogroup B:2 Provide variable Protection following Homologous Challenge in Mouse Model.” Research in Veterinary Science 98 (2015): 1-6. Print

Tabatabaei, M, Z Liu, A Finucane, R Parton, and JG Coote. “Protective Immunity Conferred by Attenuated aroA derivatives of Pasteurella multocida B:2 strains in a Mouse Model of Haemorrhagic Septicaemia.” Infection and Immunity 70.7 (2002): 3355-3362. Print

Chaudhuri, P, VP Singh, A Thamizharasan, and J Lalsiamthara. “Pasteurella multocida P52 AroA Mutant Conferred Protection to Rabbits and Mice against Haemorrhagic Septicaemia.” DHR International Journal of Biomedical and Life Sciences 3.1 (2012): 127-136. Online

Hodgson, JC, A Finucane, MP Dagleish, S Ataei, R Parton, and JG Coote. “Efficacy of Vaccination of Calves against Hemorrhagic Septicemia with a live AroA derivative of Pasteurella multocida B:2 by Two Different Routes of Administration.” Infection and Immunity 73.3 (2005): 1475-1481. Print

Dagleish, MP, JC Hodgson, S Ataei, A Finucane, J Finlayson, J Sales, R Parton, and JG Coote. “Safety and Protective Efficacy of Intramuscular Vaccination with a Live AroA derivative of Pasteurella multocida B:2 against Experimental Hemorrhagic Septicemia in Calves.” Infection and Immunity 75.12 (2007): 5837-5844. Print

Saleem, L, R Munir, G Ferrari, M Afzal, and FR Chaudhry. “Efficacy and Cross-protectivity of Live Intranasal Aerosol Hemorrhagic Septicemia Vaccine in Buffalo Calves.” International Journal of Current Microbiology and Applied Sciences 3.11 (2014): 300-307. Online

El-Eragi, AMS, MM Mukhtar, and SH Babiker. “Specific Antibodies of Pasteurella multocida in newborn calves of vaccinated dams.” Tropical Animal Health and Production 33.4 (2001): 275-283. Print

Prado, ME, TM Prado, M Payton, and AW Confer. “Maternally and Naturally Acquired Antibodies to Mannheimia haemolytica and Pasteurella multocida in Beef Calves.” Veterinary Immunology and Immunopathology 111.3 (2006): 301-307. Print

Brocchi, E, MI De Diego, A Berlinzani, D Gamba, and F De Simone. “Diagnostic Potential of mab-based ELISAs for Antibodies to Non-Structural Proteins of Foot-and-Mouth Disease Virus to Differentiate Infection from Vaccination.” Veterinary Quarterly 20.2 (1998): S20-S24. Print

Clavijo, A, EM Zhou, K Hole, B Galic, and P Kitching. “Development and Use of a Biotinylated 3ABC Recombinant Protein in a Solid-phase Competitive ELISA for the Detection of Antibodies against Foot-and-Mouth Disease Virus.” Journal of Virological Methods 120.2 (2004): 217-227. Print

Sorensen, KJ, K De Stricker, KC Dyrting, S Grazioli, and B Haas. “Differentiation of Foot-and Mouth Disease Virus Infected Animals from Vaccinated Animals using a Blocking ELISA based on Baculovirus expressed FMDV 3ABC Antigen and a 3ABC Monoclonal Antibody.” Archives of Virology 150.4 (2005): 805-814. Print

Lu, Z, Y Cao, J Guo, S Qi, D Li, Q Zhang, J Ma, H Chang, Z Liu, X Liu, and Q Xie. “Development and Validation of a 3ABC Indirect ELISA for Differentiation of Foot-and-Mouth Disease Virus Infected from Vaccinated Animals.” Veterinary Microbiology 125.1 (2007): 157-169. Print

Oem, JK, BS Chang, HD Joo, MY Yang, GJ Kim, JY Park, YJ Ko, YJ Kim, JH Park, and YS Joo. “Development of an Epitope-Blocking-Enzyme-Linked Immunosorbent Assay to Differentiate between Animals Infected with and Vaccinated against Foot-and-Mouth Disease Virus.” Journal of Virological Methods 142.1 (2007): 174-181. Print

Ray, SM, and A Singh. “Aluminum Oxide Nanoparticle-Adjuvanted Pasteurella multocida B:2 Vaccine is Potent and Efficacious and is able with Keyhole Limpet Hemocyanin as a Marker to Differentiate Infected from Vaccinated Animals (DIVA).” Research and Reviews: A Journal of Immunology 5.2 (2015): 8-16. Online



  • There are currently no refbacks.

Copyright (c) 2015 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.